Blood Transfusion Therapy in High Risk Surgical Patients by João Manoel Silva Junior & Alberto Mendonça P. Ferreira
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Blood Transfusion Therapy  
in High Risk Surgical Patients 
João Manoel Silva Junior1 and Alberto Mendonça P. Ferreira2 
1Anesthesiology and intensive care Department, 
Hospital do Servidor Público Estadual, São Paulo, 
2Intensive Care Department from Hospital do Servidor Público Estadual, São Paulo  
Brazil 
1. Introduction 
Anemia is common in surgical patients. The number of patients transfused with red blood cell 
(RBC) in the United States increased from 12.2 million, to more than 14 million most recently, 
specially in the perioperative period (Park et al. 2004). Anemia is associated with considerable 
morbidity and poor outcome. Equally, blood transfusion has been related to worse outcome, 
including in surgical patients (Sakr et al. 2010).  
Transfusion is the cornerstone of treatment for serious anemia in this population, to restore 
oxygen carrying capacity, consequently, reducing tissue hypoxia. Vincent and colleagues 
reported a 37% transfusion rate in intensive care unit (ICU) patients, and directly 73% of 
patients who remained in the ICU more than one week received transfusion (Vincent et al. 
2002). Similarly, Taylor and colleagues found 85% transfusion rate among patients who 
stayed in the ICU more than seven days (Taylor et al. 2002). 
Blood transfusion was independently associated with organ failure, longer ICU length of 
stay and increased risk of death. Possible, because deleterious effects of transfusions, 
especially, immunosuppression that is associated with nosocomial infection and directly 
related to the number of packed red cells unit used (Taylor et al. 2002). 
Another complication is the transfusion-related acute lung injury (TRALI). TRALI is 
determined as a non-cardiogenic pulmonary edema, temporary related to the transfusion 
(Looney et al. 2004). 
Besides, there were no radical changes in transfusion practice over time. Recent study has 
demonstrated that mean pre-transfusion hemoglobin was about 8.0g/l. In 30% of patients 
hemoglobin concentrations are targeted above 9g/dl (Silva Jr et al. 2008). 
Hébert and colleagues, in a randomized controlled study, investigated the impact of two 
different therapeutic strategies for anemia in ill critical patients (Hebert et al. 1999). A 
restrictive transfusion strategy (hemoglobin concentrations targeted above 7g/dl) was as 
effective as and maybe more efficient than a liberal strategy (hemoglobin concentrations 
targeted above 10g/dl). A subgroup of patients that presented unstable angina was 
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excluded. According to this evidence, it is recommended a blood transfusion trigger of 
7.0g/dl for ICU patients. 











Lower red cells production: 
Lower erythropoietin synthesis 
Erythropoietin resistence 
Iron shortage 
Erythrocytes half life decrease 
Hemolysis increase 
Table 1. Factors associated with anemia in peri-operative period 
2. Blood transfusion epidemiology 
Because of the high anemia incidence perioperatively, many patients will receive blood 
transfusion at some point. Many studies have appraised the blood transfusion epidemiology. 
In a Canadian study, enrolling 5298 people, 25% from patients received blood transfusion 
(Hebert et al. 1999). In the United Kingdom, this number escalated to 53% of 1247 patients 
during length of ICU stay. The ABC study, in 146 ICUs from Western Europe, covered 3534 
patients and showed 37% transfusion rate in ICU. Longer length of hospital stay was 
associated with blood transfusion (25% with 2 days, 56% with more than 2 days and 73% 
with more than seven days). 
In the CRIT study, 44% of the patients received one or more transfusions in ICU (Corwin et 
al. 2004). The recent SOAP (Sepsis Occurrence in Acutely ill Patients) study showed a 33% 
transfusion incidence (Vincent et al. 2008). 
Finally, a randomized study made with patients in postoperative period for cardiac surgery 
demonstrated that blood transfusion with hemoglobin trigger of 7 g/dl did not result in a 
worst clinical evolution. Otherwise, there was better outcome (Hajjar et al. 2010). 
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et al  
1999 5298 25% Significant institutional variation was 
identified in the transfusion practice 
Vincent 
et al  
1999 3534 37% For patients with similar levels of 
organ dysfunction, the ones who 
received blood transfusion displayed 
high mortality rates 
Rao et 
al  
1999 1247 53% Average pre-transfusion hemoglobin 
was greater than 9g/dl in 75% of the 
transfusions 
Corvin 
et al  
2000/2001 4892 44% The number of transfusions was 
associated with a greater length 
hospitalization and ICU stay, and 
greater mortality 
Walsh 
et al  
2001 1023 39,5% Almost half of the transfusions were 
not associated with signifcant bleeding 
French 
et al  
2001 1808 19,8% The most common transfusion 
indication was acute bleeding. Only 3% 
of the transfusions were considered 
inappropriate 
Hajjar 
et al  
2010 512 63% As greater number of transfusions as 
greater mortality within 30 days. The 
restrictive strategy resulted in less 
complications 
Table 2. Recent important studies assessing transfusion periodicity 
3. Oxygen transportation 
Hemoglobin (Hb) is essential to oxygen transportation. Human Hb is composed of 2 ǂ and 2 
ǃ chains of polypeptides. One heme group transport one molecule of oxygen (1 g of Hb ties 
1.39 mL of O2) and changes in hemoglobin affinity for oxygen correlates with change in red 
cell 2,3- Diphosphoglycerate (2,3-DPG) content, carbon dioxide, pH and body temperature. 
The 2,3-DPG molecule binds to one of the b-chains of Hb favouring deoxygenation, 
reducing hemoglobin oxygen affinity. Thereby, low 2,3-DPG concentrations increases the 
Hb affinity to O2, dislocating the oxyhemoglobin dissociation curve to the left, described as 
P50 (PO2 at which the hemoglobin becomes 50% saturated with oxygen). P50 in adults is 
26.3 mmHg (Moore et al. 2005). 
The blood concentration of hydrogen ion or carbon dioxide reduces hemoglobin oxygen 
affinity, the Bohr effect. Otherwise, the Haldane effect states that deoxygenated Hb has a 
greater affinity for CO2 than does oxyHb. Only 10% of the carbon dioxide is removed from 
the tissues as carboxyhemoglobin, 80% is removed as bicarbonate and 10% remaining as 
physical solution. 
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4. Blood transfusion risks and benefits 
Blood transfusion is safer today, however adverse are events still clinically relevant. The 
expected benefit is to improve the oxygen demand, preventing cellular injury. However, it is 
difficult to demonstrate these benefits in current clinical studies. 
Risks related to blood transfusion are divided in infectious and noninfectious. Infectious 
risks include HIV transmission, estimated in 1:676,000 transfusions in the USA and 
transmission of A, B and C hepatitis virus, estimated in 1:1,000,000, 1:63,000 and 1:103,000, 
respectively (Goodnough et al. 2003). 
Other viral infections related to transfusions are the human T-lymphotropic virus (HTLV) 
types I and II, the parvovirus B19 and the Creutzfeldt-Jacob disease, caused by a prion, 
causing encephalopathy with fast evolution to dementia. 
As viral infections, bacterial infections are also frequent complications of transfusion. The 
contamination incidence is 1 per 1,000,000 transfusion units in USA. The most important 
bacterial infections are caused by gram-negative bacteria, such as Yersinia enterocolitica, 
Serratia and Pseudomonas, which have the ability to grow even between 1 and 6 ºC. The 
contamination rate is associated with the blood packed storage time (Shorra et al. 2005). 
Immunosupression is a noninfectious complication, that increase the risk of infection. Other 
noninfectious risks are related to acute lung injury and human error, when there is an 
incorrect identification of the patients or the red blood cell package. In this case, it can cause 
hemolytic reactions. 
The transfusion related acute lung injury (TRALI) is one of the most serious complications 
by noninfectious causes and is defined as acute respiratory disease that happens within the 
first 4 hours after the transfusion. TRALI is distinguished by dyspnea and hypoxia due to 
noncardiogenic pulmonary edema. The incidence is about 1 to 5000 transfusions. The 
treatment is just support. 
 
 
Incidence frequency per a million units 
(for current unit) 
Infectious  
Virus  
Hepatitis B 4 (1/220,000) 
Hepatitis C 1 (1/800,000–1/1.6 X106) 
HIV 1 (1/1.4–2.4 X106) 
Bacteria  
Red blood cells 
2 (1/500,000) 
 
Platelets 500 (1/2,000) 
Acute hemolytic transfusion reaction 1 to 4 (1/250,000–1,000,000) 
Delayed hemolytic transfusion reaction 1000 (1/1,000) 
TRALI 125 (1/8,000) 
Adapted from Goodnough LT, et al. New Engl J Med 1999; 340:438–447. 
Table 3. Risk estimates for blood transfusions. 
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Silva Jr. and colleagues reported a 57.5% incidence of post-operative complications in ICU 
patients. Mostly frequent, up to 28 days after the blood transfusion, and included infections 
(36.3%), changes in the markers of tissue hypoperfusion (30.0%), shock (22.5%), Acute Renal 
Failure (ARF) (12.5%), cognitive changes (11.33%), fistulas of the digestive tract (6.3%), and 
ARDS (5.0%) (Silva Jr et al. 2008). 
 




Fig. 2. Relationship between the Blood Number of Units and Morbi-mortality 
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In addition, the number of units of blood transfused was directly related to the incidence of 
these complications and mortality, i.e., the greater the number of units transfused 
intraoperatively, it was higher the chances of complications and death in the postoperative 
period. (Silva Jr et al. 2008) 
5. Blood transfusion necessity assessment 
The optimal transfusion trigger in ICU patients has been a matter of controversy. The 
ongoing debate about risks and benefits regarding blood transfusions is based on a 
individual assessment, considering diagnosis and comorbidities to help therapeutic aproach.  
Serum concentrations of hemoglobin would be an easy reference and were used for years as 
a guide to start transfusions, but the optimal hemoglobin concentration varies considerably 
in each patient, according to several characteristics as age, preexisting chronic diseases 
(coronariopathy), current diagnosis and the cause of anemia. 
Using the simple hemoglobin level, below which all patients should be transfused, and 
specific values for certain groups, are also rigid. The concept of critical hemoglobin level, 
defined as the minimal hemoglobin concentration while there is no pathological O2 supply 
dependency, seems to be a reasonable indication for blood transfusion. 
There are some parameters to evaluate tissue hypoxia in clinical practice, like blood lactate, 
but this parameter indicates that the hypoperfusion is already in place and may be too late 
to indicate the point to start transfusion. However, a recent study in surgical patients 
demonstrated that transfused patients with high venous oxygen saturation had worse 
outcomes in the postoperative period (Silva JM et al. 2009). 
 
Fig. 3. Kaplan-Meier curve of transfused patients with ScvO2 80% or less and ScvO2 greater 
than 80%: (Silva JM et al. 2009). 
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Hébert and colleagues (Hebert et al. 2001) demonstrated in their study that, in critically ill 
patients, hemoglobin levels between 7 g/dl and 9 g/dl are safe (except in patients with 
myocardial infarction and unstable angina). Hajjar and colleagues (Hajjar et al. 2010) have 
also demonstrated that in postoperative cardiac patient hemoglobin level of 7 g/dl is safe 
and blood transfusion was associated with higher rates of complication. 
Today the recommendations for septic hemodinamically stable or unstable patients are to 
maintain hemoglobin levels around 7g/dl before indicate transfusion. Besides, a study in 
health volunteers with isovolumetric hemodilution and hemoglobin concentration ≤ 5.0 
g/dl, did not result in clear anaerobic metabolism (Weiskopf et a. 1998). Moreover, studies 
made with Jehovah's Witnesses patients showed that survival is possible even with lower 
hemoglobin levels. In a case report, a patient presenting hemoglobin level of 1.8 g/dL, had a 
acceptable evolution (Howell et al. 1998).  
6. Strategies to avoid blood transfusion risks 
There are several techniques to prevent blood transfusion, but they are summarized in 
blood loss optimization, blood cells production increasing and auto transfusion. 
Several evidences show that the most effective way to increase blood production is the use 
of erythropoietin in preoperative period, but the time to reach recommended hemoglobin 
values is very long, making the process very slow and not useful. 
Among the self-transfusion modes, there is the self preoperative donation (removing the 
blood before the surgery and, if needed, using it in the intraoperative or postoperative). This 
method is recommended only for patients above 20 kg . Besides that, this technique may be 
accompanied by hemodilution, allowed for patients with hematocrit above 35%. The blood 
is replaced, using crystalloid fluids to lower hematocrit to 25%, recommended for patients 
above 1 year old, because of the presence of fetal hemoglobin in neonates. Thus, this 
technique can be used shortly before surgery. 
During the intraoperative, the self-transfusion can be performed using machines that 
reutilize the lost blood on surgery. In cardiac surgeries, the blood from the extracorporeal 
circulation circuit is returned. The same technique is difficult to be performed in children, 
because the lost blood is too small to be replaced. 
In an attempt to prevent intraoperative blood losses, there are some measures such as 
desmopressin 0.3 ug/kg, which stimulates the release of von Willebrand factor, needed for 
platelets adhesiveness for damaged tissues, which does not apply to pediatric patients, and 
antifibrinolytics, preventing fibrinolysis and stabilizing clot formation. This last, in spite of 
reducing bleeding, it showed some harm potential, because it can cause thrombi, leading to 
myocardial ischemia and renal failure. Finally, the recombinant activated factor seven 
(rFVIIa) has shown positive evidence in patients with trauma and heavy bleeding. 
Another way to avoid the transfusion risks is the minimal exposure to transfusion, in other 
words, transfusion from a single donnor and permissive hypotension, in an attempt to 
prevent blood losses. But we must consider the risks and benefits, being contraindicated in 
children under 2 years and patients with systemic diseases, showing vital organs damages. 
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The transfusion reactions risks can also be minimized by the using of the leukoreduction of 
blood, which means to remove leukocytes in transfused blood, resulting in less 
immunological effects because of the transfusion, such as alloimmunization to leukocyte 
antigens, febrile reactions and TRALI. 
7. Massive transfusion 
Massive transfusion defined as a whole blood volume changed within 24 hours, a 
replacement greater than 10 units of RBC packages within 24 hours, greater than 4 units of 
RBC packages within 1 hour or a 50% replacement of total blood volume within 3 hours.  
So, the strategy used in intense and uncontrollable bleeding is to prevent the overuse of 
isotonic crystalloid solutions and to associate massive transfusions to early administration of 
products that help hemostasis (plasma, platelets and cryoprecipitate) in proportion to the 
blood transfusion, in other words, 1 erythrocytes concentrate: 1 plasma: 1 platelet, measure 




Fig. 4. Transfusion therapy summary in surgical patients. 
8. Conclusion 
Anemia is common in surgical patients and results in numerous blood transfusions. There 
are few evidences showing that blood transfusions are benefic to surgical patients. For those 
patients without active bleeding or acute cardiovascular disease, 7g/dl hemoglobin is well 
within tolerable limits. Besides hypoperfusion associated with low hemoglobin level 
appears to be an important indicator to be taken into consideration to decide for blood 
transfusion. Strategies to avoid blood losses and increase blood production may as well be 
an important tool for those patients. 
Hb≤ 7g/dl? 
Give the blood 
transfusion 
Hypovolemic? 




Give the blood 









Blood Transfusion Therapy in High Risk Surgical Patients 33 
9. References  
[1] Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on 
surgical mortality and morbidity. Lancet 1996;348:1055-60.  
[2] Chernow B: Blood conservation in critical care—The evidence accumulates. 1993; 21: 
481–482. 
[3] Corwin HL, Gettinger A, Pearl RG, et al: The CRIT Study: Anemia and blood transfusion 
in the critically ill—Current clinical practice in the United States. Crit Care Med 
2004; 32: 39–52. 
[4] Dellinger RP, Carlet JM, Masur H, et al: Surviving sepsis campaign guidelines for 
management of severe sepsis and septic shock. Crit Care Med 2004; 32:858–873. 
[5] French CJ, Bellomo R, Finfer SR, et al: Appropriateness of red blood cell transfusion in 
Australasian intensive care practice. Med J Aust 2002; 177:548–551. 
[6] Foulke GE, Harlow DJ: Effective measures for reducing blood loss from diagnostic 
laboratory tests in intensive care unit patients. Crit Care Med 1989; 1143–1145. 
[7] Goodnough LT: Risks of blood transfusion. Crit Care Med 2003; 31(2): S678-S686. 
[8] Hajjar LA.; Vincent JL; Galas FRBG.; et al. Transfusion Requirements After Cardiac 
Surgery: The TRACS Randomized Controlled Trial. JAMA. 2010;304(14):1559-1567 
[9] Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in 
critically ill patients? Am J Respir Crit Care Med 1997; 155:1618-23. 
[10] Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled 
clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409–
417 
[11] Hebert PC, Wells G, Martin C, et al: Variation in red cell transfusion practice in the 
intensive care unit: A multicentre cohort study. Crit Care 1999; 3:57–63. 
[12] Hebert PC, Yetisir E, Martin C, et al: Is a low transfusion threshold safe in critically ill 
patients with cardiovascular diseases? Crit Care Med 2001; 29:227–234. 
[13] Howell PJ, Bamber PA: Severe acute anaemia in a Jehovah’s Witness. Survival without 
blood transfusion. Anaesthesia 1987; 42: 44–48. 
[14] Looney MR, et al. Transfusion-Related Acute Lung Injury. A Review. CHEST 2004; 
126:249-258.  
[15] Madjdpour C, Spahn DR, Weiskopf RB: Anemia and perioperative red blood cell 
transfusion: A matter of tolerance. Crit Care Med 2006; 34 (5): 102S-108S. 
[16] Moore EE., Johnson JL., Cheng AM., et al: Insights from studies of blood substitutes in 
trauma. Shock 2005; 24( 3): 197–205  
[17] Park KW. Chandhok D. Transfusion-associated complications. International 
Anesthesiology Clinics. 42(3):11-26, 2004.  
[18] Rao MP, Boralessa H, Morgan C, et al: Blood component use in critically ill patients. 
Anaesthesia 2002; 57:530–534. 
[19] Robinson WP III, Ahn J, Stiffler A, et al. Blood transfusion is an independent predictor 
of increased mortality in nonoperatively managed blunt hepatic and splenic 
injuries. J Trauma 2005;58:437-44. 
[20] Russell JA, Phang PT. The oxygen delivery/consumption controversy: an approach to 
management of the critically ill. Am J Respir Crit Care Med 1994;149:533-7.  
[21] Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K. 




Blood Transfusion in Clinical Practice 34
[22] Shorra AF, Jacksonb WL: Transfusion practice and nosocomial infection: assessing the 
evidence. Current Opinion in Critical Care 2005; 11:468-472. 
[23] Silliman CC, et al. Transfusion-Related Acute Lung Injury. Review Article. Blood 2005; 
105:2266-2273.  
[24] Silva JM Jr, Toledo DO, Magalhães DD, Pinto MA, Gulinelli A, Sousa JM, da Silva IF, 
Rezende E, Pontes-Arruda A. Influence of tissue perfusion on the outcome of 
surgical patients who need blood transfusion. J Crit Care. 2009;24(3):426-34. 
[25] Silva Jr João Manoel, Cezario T Abreu, Toledo Diogo O, Magalhães D Dourado, Pinto M 
Aurélio Cícero, Victoria L Gustavo F. Complications and prognosis of 
intraoperative blood transfusion. Rev. Bras. Anestesiol.  2008; 58(5): 447-46. 
[26] Taylor RW, Manganaro L, O’Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of 
allogenic packed red blood cell transfusion on nosocomial infection rates in the 
critically ill patient. Crit Care Med 2002;30:2249-54. 
[27] Vincent JL, Baron JF, Reinhart K, et al: Anemia and blood transfusion in critically ill 
patients. JAMA 2002; 288:1499–1507. 
[28] Vincent JL, Piagnerelli M. Transfusion in the intensive care unit. Crit Care Med 2006; 34, 
No. 5 (Suppl.): S96-S101. 
[29] Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P: Are blood transfusions associated 
with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients 
study. Anesthesiology 2008, 108: 31-39.  
[30] Walsh TS, Garrioch M, Maciver C, et al: Red cell requirements for intensive care units 
adhering to evidence-based transfusion guidelines. Transfusion 2004; 44:1405–1411. 
[31] Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular and metabolic response 
to acute, severe isovolemic anemia. JAMA 1998; 279:217–221. 
www.intechopen.com
Blood Transfusion in Clinical Practice
Edited by Dr. Puneet Kochhar
ISBN 978-953-51-0343-1
Hard cover, 272 pages
Publisher InTech
Published online 16, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Blood Transfusion in Clinical Practice focuses on the application of blood transfusion in different clinical
settings. The text has been divided into five sections. The first section includes a chapter describing the basic
principles of ABO blood group system in blood transfusion. The second section discusses the use of
transfusion in various clinical settings including orthopedics, obstetrics, cardiac surgery, etc. The third section
covers transfusion transmitted infections, while section four describes alternative strategies to allogenic blood
transfusion. The last section speculates over immunomodulatory effects of blood transfusion.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
João Manoel Silva Junior and Alberto Mendonça P. Ferreira (2012). Blood Transfusion Therapy in High Risk
Surgical Patients, Blood Transfusion in Clinical Practice, Dr. Puneet Kochhar (Ed.), ISBN: 978-953-51-0343-1,
InTech, Available from: http://www.intechopen.com/books/blood-transfusion-in-clinical-practice/blood-
transfusion-therapy-in-surgical-patients
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
